Business
NuGen M.D. Announces the Departure of its President and CEO and Immediate Appointment of New Interim Chief Executive Officer and Interim Chief Customer Officer
TORONTO, ON / ACCESSWIRE / December 15, 2022 / The Board of directors of NuGen Medical Devices ...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen M.D. Announces the Departure of its President and CEO and Immediate Appointment of New Interim Chief Executive Officer and Interim Chief Customer OfficerTORONTO, ON / ACCESSWIRE / December 15, 2022 / The Board of directors of NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (\"NuGen'' or the \"Company\"), a leader in needle-free drug delivery, announces the departure of Mr. Michael Wright, President and Chief Executive Officer, effective immediately. Mr. Wright remains a director and a shareholder of the Company and will assist with the management transition. The Company wishes Mr. Wright good luck with his future endeavors.The Board is pleased to announce the immediate appointment of Mrs. Karen Dunlap, a current director of NuGen, as Interim Chief Customer Officer (CCO) and Mr. Derek Lindsay, also a current director of NuGen, as Interim Chief Executive Officer (CEO). Mr. Nicky Canton remains Chief Operating Officer (COO) of the Company and Mrs. Veronique Laberge remains Chief Financial Officer (CFO) of the Company.Karen Dunlap, CCO, was President & COO of Sol-Millennium Medical, now a key distribution partner of the Company. To open non-North American markets, Karen completed a Joint Venture in Brazil and immediately went to market and subsequently opened offices in the EU and UK. Karen's background specializes in start-up companies bringing new technology to market, working together with end-users, manufacturing, marketing and sales on developing and design of safe medication delivery systems. Karen has extensive experience in both domestic and international health care management covering all facets of business, including product development, manufacturing, operations, P & L, sales, marketing and strategic planning for a number of emerging medical technology companies. Karen has developed strong relationships within the industry on the launch of new products and has extensive knowledge and experience of the global medical technology market.Derek Lindsay, CEO, is a seasoned international executive with long experience scaling high potential companies in the medical device, telecom and other high growth sectors. He has a proven track record of creating value for shareholders, raising capital, and a strong financial discipline. Mr. Lindsay was CFO of Cryocath, a publicly traded medical device company that was re...